UroGen Pharma Ltd.

URGN | NASDAQ

Price Alert Chart Builder DCF Calculator

$43.20

-$0.05 (-0.12%)

At close: Sep 21, 2026, 4:00 PM ET

$44.20

+$1 (+2.31%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-153.49M	-126.87M	-102.24M	-109.78M	-110.82M	-128.48M
Depreciation & Amortization	2.41M	1.19M	1.71M	1.82M	1.77M	2.04M
Stock-Based Compensation	11.96M	13.11M	9.34M	10.58M	23.11M	28.03M
Other Working Capital	-8.18M	2.45M	3.27M	-5.24M	-7.57M	3.89M
Other Non-Cash Items	4.59M	10.88M	11.48M	16.13M	-1.18M	-1.54M
Deferred Income Tax	n/a	n/a	n/a	n/a	15.32M	439K
Change in Working Capital	-27.91M	4.93M	3.34M	-6.31M	-13.11M	-6.37M
Operating Cash Flow	-162.44M	-96.77M	-76.38M	-87.56M	-84.89M	-105.89M
Capital Expenditures	-289K	-295K	-194K	-254K	-752K	-1.22M
Cash Acquisitions	n/a	n/a	n/a	-1.31M	-4.82M	-94.45M
Purchase of Investments	-77.4M	-128.02M	-49.83M	-63.01M	-51.9M	-29.69M
Sales Maturities Of Investments	139.25M	107.71M	49.07M	64.32M	56.72M	124.14M
Other Investing Acitivies	n/a	n/a	n/a	1.31M	4.82M	94.45M
Investing Cash Flow	61.56M	-20.61M	-953K	1.06M	4.07M	93.24M
Debt Repayment	-1.86M	24.49M	n/a	95.78M	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	18.96M	49.57M	-160K	72.4M	674K
Financial Cash Flow	39.92M	194.62M	116.93M	97.13M	72.32M	16.53M
Net Cash Flow	-60.97M	77.24M	39.6M	10.64M	-8.5M	3.88M
Free Cash Flow	-162.73M	-97.06M	-76.57M	-87.81M	-85.64M	-107.1M
Adj. Free Cash Flow	-174.69M	-110.17M	-85.91M	-98.39M	-108.76M	-135.13M
Maintenance CapEx	n/a	n/a	n/a	n/a	n/a	n/a
Growth CapEx	-289K	-295K	-194K	-254K	-752K	-1.22M
Owner Earnings	-162.44M	-96.77M	-76.38M	-87.56M	-84.89M	-105.89M